Published in J Clin Invest on September 01, 1988
Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci U S A (1993) 2.24
A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A (1989) 1.61
Liver X receptors regulate adrenal cholesterol balance. J Clin Invest (2006) 1.45
Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. J Clin Invest (1992) 1.32
Understanding endorphins and their importance in pain management. Hawaii Med J (2010) 1.01
Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro. J Clin Invest (1988) 0.95
Organization and Integration of the Endocrine System. Sleep Med Clin (2007) 0.90
Immune system-central nervous system interactions: effect and immunomodulatory consequences of immune system mediators on the brain. Antimicrob Agents Chemother (1994) 0.87
Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. J Clin Invest (1993) 0.85
Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress. Front Neurosci (2015) 0.81
EVALUATION OF PLASMA SUBSTANCE P AND BETA-ENDORPHIN LEVELS IN CHILDREN WITH PRADER-WILLI SYNDROME. J Rare Disord (2015) 0.78
Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression. J Psychiatry Neurosci (1993) 0.77
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol (1978) 13.02
ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY. Science (1964) 4.93
Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology (1983) 4.67
Corticosteroid inhibition of ACTH secretion. Endocr Rev (1984) 2.42
Classification of opioid receptors. Br Med Bull (1983) 2.12
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev (1978) 1.37
The use of corticotrophin production by adenohypophysial tissue in vitro for the detection and estimation of potential corticotrophin releasing factors. J Endocrinol (1977) 1.36
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36
Mapping of glucocorticoid receptor immunoreactive neurons in the rat tel- and diencephalon using a monoclonal antibody against rat liver glucocorticoid receptor. Endocrinology (1985) 1.32
Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology (1987) 1.18
Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res (1987) 1.07
Hypothalamic and pituitary sites of action of oxytocin to alter prolactin secretion in the rat. Endocrinology (1983) 1.07
Corticotropin-releasing factor receptors in rat forebrain: autoradiographic identification. Science (1984) 1.06
Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinology (1987) 1.02
Presence of corticotropin in brain of normal and hypophysectomized rats. Proc Natl Acad Sci U S A (1977) 1.01
Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro). Brain Res (1986) 0.98
Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. Proc Natl Acad Sci U S A (1985) 0.94
Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids. Endocrinology (1984) 0.93
Effects of implantation of cortisol into the brain stem or pituitary gland on the adrenal response to stress in the rabbit. Acta Endocrinol (Copenh) (1962) 0.93
A "short" feedback loop in the control of ACTH secretion. Endocrinology (1965) 0.92
Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. Brain Res (1983) 0.91
Self-regulation of adrenocorticotropin secretion by mouse pituitary tumor cells in culture. Endocrinology (1978) 0.90
In vivo secretion of LHRH in ovariectomized rats is regulated by a possible autofeedback mechanism. Neuroendocrinology (1987) 0.87
beta-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects. J Clin Endocrinol Metab (1983) 0.86
Effects of intraventricular growth hormone-releasing factor on growth hormone release: further evidence for ultrashort loop feedback. Endocrinology (1985) 0.86
Immunoreactive ACTH in cerebrospinal fluid. J Clin Endocrinol Metab (1974) 0.86
Effect of dexamethasone on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary. Endocrinology (1984) 0.85
A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamus-pituitary-adrenal system in vitro. II. Hypothalamus-pituitary cell-adrenal cell superfusion. Endocrinology (1977) 0.85
Characterization of a calf hypothalamic extract with adrenocorticotropin-releasing properties: evidence for a central nervous system site for corticosteroid inhibition of adrenocorticotropin release. Endocrinology (1962) 0.85
Directional pituitary blood flow: a microcinephotographic study. Endocrinology (1983) 0.84
Effect of bilateral adrenalectomy and corticosteroid therapy on the secretion of corticotrophin-releasing factor activity from the hypothalamus of the rat in vitro. J Endocrinol (1976) 0.84
Modulation of corticotrophin-releasing factor release from hypothalamic synaptosomes. Nature (1974) 0.84
Stimulation and inhibition of corticotrophin releasing factor secretion by beta endorphin. Neuroendocrinology (1986) 0.84
Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro. Neuroendocrinology (1988) 0.84
The distribution and cells of origin of ACTH(1-39)-stained varicosities in the paraventricular and supraoptic nuclei. Brain Res (1982) 0.83
Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin-releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology (1986) 0.83
Immunoreactive corticotropin-releasing factor concentrations in cerebrospinal fluid from patients with hypothalamic-pituitary-adrenal disorders. J Clin Endocrinol Metab (1983) 0.83
Suppressive effect of dexamethasone on the rise of CRF activity in the median eminence induced by stress. Endocrinology (1971) 0.83
Localization and specificity of corticosteroid "feedback receptors" at the hypothalamo-hypophyseal level; comparative effects of various steroids implanted in the median eminence or the anterior pituitary of the rat. Neuroendocrinology (1970) 0.82
Fast, rate-sensitive corticosteroid negative feedback during stress. Am J Physiol (1978) 0.82
Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. Endocrinology (1986) 0.82
Cerebral involvement in the inhibition of ACTH secretion by hydrocortisone. Endocrinology (1963) 0.82
Effects of bilateral adrenalectomy on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary. Endocrinology (1983) 0.82
Feedback mechanisms regulating pituitary ACTH secretion in rats bearing transplantable pituitary tumors. Endocrinology (1967) 0.81
Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab (1985) 0.81
Characterization of corticotropin-like immunoreactive peptides in rat brain using high performance liquid chromatography. Neurosci Lett (1982) 0.81
Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci (1987) 0.81
Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J Clin Endocrinol Metab (1982) 0.80
Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro. Life Sci (1986) 0.80
In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus. Life Sci (1985) 0.79
Effects of adrenocortical and gonadal steroids on the secretion in vitro of corticotrophin and its hypothalamic releasing factor. J Endocrinol (1982) 0.78
No "ultra-short feedback mechanism" for ACTH. Neuroendocrinology (1974) 0.78
Adrenocorticotropin immunoactivity in monkey hypophyseal portal blood. J Clin Endocrinol Metab (1984) 0.77
EFFECTS OF INTRAHYPOTHALAMIC CRYSTALLINE STEROIDS ON ACUTE ACTH SECRETION. Am J Physiol (1963) 0.77
Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro. Brain Res (1986) 0.77
A correlative study of the binding of dexamethasone in hypothalamic blocks in vitro with its ability to inhibit the release of bioactive corticotrophin-releasing factor. J Steroid Biochem (1985) 0.77
Evidence for ultra-short loop autoregulation of adrenocorticotropin secretion in man. J Clin Endocrinol Metab (1988) 0.76
Influence of morphine anaesthesia on the endocrine-metabolic response to open-heart surgery. Acta Anaesthesiol Scand (1978) 0.76
Biphasic inhibition of bioactive hypothalamic corticotrophin releasing factor secretion in vitro by corticosterone and prevention of the second phase by various steroids. J Endocrinol (1983) 0.76
Inhibition of rat hypothalamic somatostatin release by somatostatin: evidence for somatostatin ultrashort loop feedback. Endocrinology (1986) 0.76
The action of dexamethasone and vasopressin on hypothalamic CRF production and release. Neuroendocrinology (1969) 0.76
EFFECT OF HYPOTHALAMIC AND MESENCEPHALIC STEROID IMPLANTATIONS ON ACTH FEEDBACK MECHANISMS. Endocrinology (1965) 0.76
A short negative feedback mechanism regulating corticotropin-releasing hormone release. J Clin Endocrinol Metab (1987) 0.76
EFFECT OF INTRACEREBRAL IMPLANTATION OF HYDROCORTISONE ON ADRENOCORTICAL SECRETION AND ADRENAL WEIGHT AFTER UNILATERAL ADRENALECTOMY. Acta Physiol Acad Sci Hung (1964) 0.76
The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. JAMA (1992) 6.96
The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40
Adverse effects of modest sleep restriction on sleepiness, performance, and inflammatory cytokines. J Clin Endocrinol Metab (2004) 4.48
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab (2000) 4.34
Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol Psychiatry (2002) 3.82
Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab (2003) 3.33
The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med (1998) 3.16
Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implications. J Clin Endocrinol Metab (2001) 2.97
Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med (1991) 2.93
Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med (1997) 2.73
Hypothalamic-pituitary-adrenal axis dysregulation in sexually abused girls. J Clin Endocrinol Metab (1994) 2.71
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1) N Engl J Med (1988) 2.58
Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A (1989) 2.43
Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab (1999) 2.40
Circulating leptin levels during acute experimental endotoxemia and antiinflammatory therapy in humans. J Infect Dis (1998) 2.27
Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab (1991) 2.23
Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab (1994) 2.22
Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest (1995) 2.20
Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol (1993) 2.20
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A (2000) 2.19
Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-alpha antagonist. J Clin Endocrinol Metab (2004) 2.11
Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids. Endocr Rev (1996) 2.11
Chronic insomnia and activity of the stress system: a preliminary study. J Psychosom Res (1998) 2.06
Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med (1993) 2.05
"Leaner and less fit" children have a better cardiometabolic profile than their "heavier and more fit" peers: the Healthy Growth Study. Nutr Metab Cardiovasc Dis (2013) 2.04
Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum (1994) 1.97
Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) N Engl J Med (1988) 1.95
Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest (1996) 1.94
Short sleep duration and obesity: the role of emotional stress and sleep disturbances. Int J Obes (Lond) (2008) 1.86
Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab (1998) 1.80
Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res (1994) 1.80
Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease. Ann Intern Med (1999) 1.79
Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. J Clin Endocrinol Metab (1997) 1.79
Metabolic disturbances in obesity versus sleep apnoea: the importance of visceral obesity and insulin resistance. J Intern Med (2003) 1.78
Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med (1994) 1.78
Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Ann Intern Med (1998) 1.74
Chronic insomnia is associated with a shift of interleukin-6 and tumor necrosis factor secretion from nighttime to daytime. Metabolism (2002) 1.71
Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science (1991) 1.70
Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A (2000) 1.69
Lack of utility of (111)In-pentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab (1999) 1.68
Mechanisms of stress: a dynamic overview of hormonal and behavioral homeostasis. Neurosci Biobehav Rev (1992) 1.66
Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6. J Clin Endocrinol Metab (1997) 1.65
Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab (1993) 1.65
IL-6 and its circadian secretion in humans. Neuroimmunomodulation (2005) 1.64
Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor beta. J Exp Med (1997) 1.61
Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats. Neuroendocrinology (1990) 1.61
A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal cell wall-induced arthritis in Lewis rats. Proc Natl Acad Sci U S A (1989) 1.61
Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol (1998) 1.59
In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation. Endocrinology (1996) 1.57
Thyroid hormone concentrations in depressed and nondepressed adolescents: group differences and behavioral relations. J Am Acad Child Adolesc Psychiatry (1996) 1.57
Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation (1998) 1.57
Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res (1990) 1.57
Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol (2000) 1.54
Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab (2001) 1.53
IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab (2001) 1.53
Allostasis, amygdala, and anticipatory angst. Neurosci Biobehav Rev (1994) 1.52
Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology (1998) 1.52
Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol (2000) 1.52
Behavioral and neuroendocrine responses in shy children. Dev Psychobiol (1997) 1.50
Acute hypothalamic-pituitary-adrenal responses to the stress of treadmill exercise. Physiologic adaptations to physical training. N Engl J Med (1987) 1.50
Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat Med (1996) 1.46
Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. Pathophysiologic and diagnostic implications. N Engl J Med (1986) 1.45
The stress response and the regulation of inflammatory disease. Ann Intern Med (1992) 1.44
The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J Exp Med (1999) 1.43
Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma. Am J Respir Crit Care Med (1999) 1.43
Immunohistochemical and ultrastructural localization of leptin and leptin receptor in human white adipose tissue and differentiating human adipose cells in primary culture. Diabetes (2000) 1.43
Neuroendocrinology and pathophysiology of the stress system. Ann N Y Acad Sci (1995) 1.42
Relation of clinical variables to dissociative phenomena in eating disorders. Am J Psychiatry (1990) 1.42
Plasma leptin in men and women with seasonal affective disorder and in healthy matched controls. Horm Metab Res (2005) 1.42
Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J Clin Endocrinol Metab (1999) 1.41
A healthy body in a healthy mind--and vice versa--the damaging power of "uncontrollable" stress. J Clin Endocrinol Metab (1998) 1.41
Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab (1996) 1.41
The endocrinology of melancholic and atypical depression: relation to neurocircuitry and somatic consequences. Proc Assoc Am Physicians (1999) 1.41
Behavioral and psychophysiological correlates of self-presentation in temperamentally shy children. Dev Psychobiol (1999) 1.40
Neuroendocrinology of stress. Endocrinol Metab Clin North Am (2001) 1.40
High constitutive glucocorticoid receptor beta in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med (2001) 1.39
Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women. Proc Natl Acad Sci U S A (1998) 1.39
Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab (2001) 1.38
The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med (1984) 1.36
The non-ligand binding beta-isoform of the human glucocorticoid receptor (hGR beta): tissue levels, mechanism of action, and potential physiologic role. Mol Med (1996) 1.35